Dear Sir,
In pregnancies with hypertensive disorders, the blood pressure and vascular resistance are increased, blood volume is smaller, and blood pressure and heart rate responses to various provocations are changed compared to those of normotensive pregnant women. 1, 2 In the pathogenesis of hypertensive disorders in pregnancies, especially in pre-eclampsia, the shallow endovascular cytotrophoblast invasion in the spiral arteries 3 and the following systemic endothelial cell dysfunction of pregnant women are two key features. 4 , 5 The precise classification of distinct hypertensive pregnancy disorders is very often difficult in clinical practice due to methodological limitations. Heart rate variability (HRV) and blood pressure variability (BPV) are useful tools to differentiate between different cardiovascular disorders and predict mortality of those patients. 6, 7 To evaluate HRV and BPV as potential diagnostic tools for different hypertensive pregnancy disorders, we initiated a pilot study to determine whether these variability parameters can distinguish between pregnancy-induced hypertension (PIH) and pre-eclampsia (PE).
In this cross-sectional study, 23 healthy pregnant women (age: 28 7 5 years, gestational week: 33 7 4), 14 women with PIH (age: 28 7 6 years, gestational week: 34 7 5), and 15 women with-PE (age: 28 7 5 years, gestational week: 30 7 3) were recruited from the Department of Obstetrics and Gynecology, University of Leipzig. Approval of the study was obtained from the medical scientific and ethical committee of the University of Leipzig. All diagnoses at admission were re-examined and confirmed 6 weeks after delivery. The classification of the hypertensive disorders is according to the 'National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy'. 5 To analyse blood pressure waveform in addition to HRV, BPV, and baroreflex sensitivity (BRS), synchronously high-resolution ECG (1600 Hz) and noninvasive continuous blood pressure were recorded via finger cuff (200 Hz, PORTAPRES device Model 2, BMI-TNO, Amsterdam, The Netherlands).
All measurements were performed over 30 min under standardized resting conditions between 8 am and 12 am as described previously by Voss et al. 8 The parameters of BPV evaluated by our group differ between normotensive pregnant women and those with hypertensive pregnancy diseases. 9 For instance, patients with PIH were characterized by significant increases of various time and frequency parameters in low-and high-frequency domains compared to normotensive pregnancies, but no additional parameter of BPV is changed in PE. However, no parameter of BPV has been found yet that was able to achieve a 100% discrimination between PIH and PE. 9 Moreover, the preliminary analysis of the pilot study showed that also the introduction of HRV and BRS parameters did not allow a precise and clinically feasible classification of the hypertensive pregnancy disorders. Since PE is thought to be a general endothelial disease, it should be distinguishable from PIH as a 'normal' hypertensive disorder. 5 We therefore analysed various parameters of the blood pressure waveform (Figure 1, panel a) , since the shape of this curve is modulated by peripheral vessel resistance and reflects mainly endothelial function. A number of waveform parameters showed significant differences between the two hypertensive disorders in pregnancy (data not shown). Further analysis revealed the surprising fact that one parameter, Amp1, is significantly increased in the pre-eclamptic patients and that only the use of Amp1 enabled the correct classification of PE (Figure 1, panel b) compared to normal pregnancies as well as PIH (P ¼ 0.0000066). This parameter Amp1 is the pressure amplitude of one heart action, that is, the difference between maximal systolic and minimal diastolic blood pressure. Interestingly, only one patient who was diagnosed as having PE at admission due to hypertension plus mild proteinuria did not show an increased Amp1. Exactly this woman had to be reclassified as a chronic hypertension by a follow-up examination 12 weeks after delivery. The increased Amp1 in PE reflects an increased difference between diastolic and systolic blood pressure, and is caused by a reduced vascular reactivity resulting from generalized endothelial dysfunction. At present, there is overwhelming evidence for endothelial damage in PE. This dysfunction includes morphological changes like renal endotheliosis and structural changes in the uteroplacental vessels as well as functional problems of the endothelium. Increased concentrations of the Von Willebrand factor and endothelin and an altered balance between PGI 2 and TxA 2 influence vascular tone and peripheral resistance. 10 Previous investigations such as the measurement of the flowmediated dilation of the brachial artery showed that this impaired endothelial function and reduced vasorelaxation can be measured in pregnant women with PE. 11 Thus, our results clearly indicate a different pathophysiology for the two hypertensive disorders, PIH and PE, characterize PE as an endothelial disease, and demonstrate that the complex alterations in endothelial function and vascular regulation have impact on the blood pressure waveform. Previous studies aimed to give a complex description of blood pressure patterns in normal and hypertensive pregnancies using the circadian blood pressure variability or the 24-h blood pressure amplitude. 12 However, for clinical practice and an early prediction of PE a simple and reliable test is needed. To our knowledge, there are no reports about the blood pressure amplitude and its analysis as performed in our study. Moreover, we are the first to describe a single as well as simple blood pressure parameter that discriminates between PIH and PE and may enable obstetricians to classify borderline patients. Since it can be estimated that a number of hypertensive pregnancy diseases are not correctly classified and particularly a number of pre-eclamptic women have an undetected chronic hypertension, the described method might become clinically relevant. A more accurate diagnosis of a hypertensive pregnancy disease using blood pressure curve analysis should improve identification of high-risk patients as well as their management and treatment. Considering this fact, it seems amazing that such a simple parameter like the blood pressure amplitude has not been investigated yet. One has to state that a precise blood pressure waveform analysis including amplitude (Amp1) requires an advanced method like the PORTAPRES technique described by our group and cannot be achieved with a conventional blood pressure cuff.
Further studies are needed to determine whether this increase of Amp1, specific for PE, is detectable prior to the clinical manifestation of the disease and if this parameter has a predictive value, possibly in combination with the assessment of uterine artery doppler waveforms. Furthermore, we want to evaluate its possible use as an ambulatory test and its ability to differentiate between all types of hypertensive disorders of pregnancy. 
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